Search results

Slaughter and May is advising Hikma Pharmaceuticals PLC in relation to its acquisition of Medlac Pharma Italy, Co. Ltd. Hikma Pharmaceuticals PLC in relation to its acquisition of Medlac Pharma Italy, Co. Ltd. Slaughter and May advised AngloGold Ashanti on a new five-year revolving credit facility with a syndicate of fourteen banks AngloGold Ashanti - new multi-currency US$1.4 billion, five-year unsecured revolving credit facility Slaughter and May advises Blackstone, alongside Goldman Sachs, on investment in Prima Assicurazioni Blackstone, alongside Goldman Sachs, on investment in Prima Assicurazioni Slaughter and May advised Amyris, Inc on its collaboration with Yifan Pharmaceutical Slaughter and May advised Amyris, Inc. (Amyris) on its collaboration arrangements with a subsidiary of Yifan Pharmaceutical Co., Ltd. (Yifan). Slaughter and May is advising Banco Santander, S.A., in connection with the proposed merger of Alawwal bank with The Saudi British Bank Slaughter and May is advising Banco Santander, S.A. (“Santander”), a significant shareholder in Alawwal bank, in connection with the proposed merger of Alawwal bank with The Saudi British Bank (the “Merger”). Slaughter and May is acting for Wonga Group in respect of the decision to place it into administration Wonga Group in respect of the decision to place it into administration Slaughter and May advised CEVA Logistics AG on its comprehensive $1.4bn refinancing CEVA Logistics AG on its comprehensive $1.4bn refinancing Slaughter and May is acting for GI Partners in connection with a recommended offer by CareTech Holdings PLC for Cambian Group plc GI Partners in connection with a recommended offer by CareTech Holdings PLC for Cambian Group plc Slaughter and May is advising esure Group plc in connection with the takeover offer made by Bain Capital esure Group plc in connection with the takeover offer made by Bain Capital Slaughter and May advised Close Brothers Limited on the annual update and revision of its £2 billion Euro Medium Term Note programme Close Brothers Limited on the annual update and revision of its £2 billion Euro Medium Term Note programme